Yet Another ‘Final’ TPP Ministerial and Again No Deal; Not Surprising Given Growing Controversy Over TPP Threats Here and in Other Nations
Statement of Lori Wallach, Director, Public Citizen’s Global Trade Watch
Today’s fourth “final” TPP ministerial without a deal means the clock has run on possible U.S. congressional votes in 2015. No deal means the TPP is thrown into the political maelstrom of the U.S. presidential cycle and with opposition building in many countries there are reduced chances that a deal will ever be reached on a pact that U.S. Trade Representative Michael Froman declared to be in its “end game” in 2013 but that has become ever more controversial since.
It’s good news for people and the planet that no deal was done at this final do-or-die meeting given the TPP’s threats to jobs, wages, safe food, affordable medicines and more. Only the beleaguered negotiators and most of the 600 official U.S. trade advisors representing corporate interests wanted this deal, which recent polling shows is unpopular in most of the countries involved.
This ministerial was viewed as a do-or-die moment to inject momentum into the TPP process, so this Maui meltdown in part reflects how controversial the TPP is in many of the involved nations and how little latitude governments feel to make concessions to get a deal.
The intense U.S. national political battle over trade authority was just a preview of the massive opposition the TPP would face once members of Congress and the public see the specific TPP terms that threaten their interests. Given the damaging impacts that some TPP proposals could have for many people, it’s not surprising that the same set of issues including investor-state dispute resolution and medicine patents as well as market access issues like sugar, dairy, and rules-of-origin on manufactured goods like autos remain deadlocked given they will determine whether a final pact is politically viable in various TPP countries.
Many of the 28 House Democrats who supported Fast Track authority for Obama explicitly said that their support for the TPP relied on certain goals being met, including strong, enforceable labor and environmental standards, and no rolling back of past patent rule reforms relating to access to medicines – terms meeting the “May 2007” standard that elements of the TPP do not meet.